2024

• Shurmelova I, Baldyga A, Grekowitz E, Kimeswenger S, Hoetzenecker W, Maurer M, Altrichter S. (2024). Skin reaction patterns in cholinergic urticaria. Allergol International. doi: 10.1016/j.alit.2024.07.008. 
• Altrichter S, Giménez-Arnau AM, Bernstein JA, Metz M, Bahadori L, Bergquist M, Brooks L, Ho CN, Jain P, Lukka PB, Rodriguez-Suárez E, Walton C, Datto CJ; ARROYO Study Investigators. (2024) Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial. Br J Dermatol. 2024 Jul 16;191(2):187-199. doi: 10.1093/bjd/ljae067.
• Ettinger M, Kimeswenger S, Deli I, Traxler J, Altrichter S, Noack P, Wikstrom JD, Guenova E, Hoetzenecker W. (2024) Darier disease: Current insights and challenges in pathogenesis and management. J Eur Acad Dermatol Venereol. 2024 Nov 28. doi: 10.1111/jdv.20448. 
• Holzgruber J, Martins C, Kulcsar Z, Duplaine A, Rasbach E, Migayron L, Singh P, Statham E, Landsberg J, Boniface K, Seneschal J, Hoetzenecker W, Berdan EL, Ho Sui S, Ramsey MR, Barthel SR, Schatton T. (2024) Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade.Nat Commun. 2024 Aug 26;15(1):7165. doi: 10.1038/s41467-024-51496-2.
• Chang YT, Prompsy P, Kimeswenger S, Tsai YC, Ignatova D, Pavlova O, Iselin C, French LE, Levesque MP, Kuonen F, Bobrowicz M, Brunner PM, Pascolo S, Hoetzenecker W, Guenova E. (2024) MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides. Nat Commun. 2024 Jan 25;15(1):752. doi: 10.1038/s41467-024-45083-8.

2023

• Ettinger, M., Burner, T., Sharma, A., Chang, Y., Lackner, A., Prompsy, P., Deli, I., Traxler, J., Wahl, G., Altrichter, S., Langer, R., Tsai, Y., Varkhande, S., Schoeftner, L., Iselin, C., Gratz, I., Kimeswenger, S., Guenova, E., Hoetzenecker, W. (2023). Th17-associated cytokines IL-17 and IL-23 in inflamed skin of Darier disease patients as potential therapeutic targets. Nature Communications. 14. 10.1038/s41467-023-43210-5
• Ettinger, M., Burner, T., Pospischil, I., Traxler, J., Wahl, G., Altrichter, S., Lackner, A., G., Kimeswenger, S., Guenova, E., Hoetzenecker, W. (2023). Targeting of Th17-related cytokines in patients with Darier Disease. 10.1101/2023.01.12.22283857

2022

• Ettinger, M., Burner, T., Lackner, A., Schoeftner, L., Holzgruber, J., Gruber, R., Guenova, E., Schuetz‐Bergmayr, M., Fischer, T., Gratz, I., Kimeswenger, S., Hoetzenecker, W. (2022). Precision medicine approach in a rare case of autosomal recessive congenital ichthyosis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 20. 10.1111/ddg.14923.

2021

• Altrichter, S., Fok, J. S., Jiao, Q., Kolkhir, P., Pyatilova, P., Moñino Romero, S., Scheffel, J., Siebenhaar, F., Steinert, C., Terhorst-Molawi, D., Xiang, Y., Church, M., Maurer, M. (2021). Total IgE as a Marker for Chronic Spontaneous Urticaria. Allergy, Asthma & Immunology Research. 13. 206-218. 10.4168/aair.2021.13.2.206.

2020

• Kimeswenger, S., Tschandl, P., Noack, P., Hofmarcher, M., Rumetshofer, E., Kindermann, H., Silye, R., Hochreiter, S., Kaltenbrunner, M., Guenova, E., Klambauer, G., Hoetzenecker, W. (2020). Artificial neural networks and pathologists recognize basal cell carcinomas based on different histological patterns. Modern Pathology. 34. 10.1038/s41379-020-00712-7.

2019

• Kimeswenger, S., Rumetshofer, E., Hofmarcher, M., Tschandl, P., Kittler, H.,& Hochreiter, S.,& Hoetzenecker, W., Klambauer, G. (2019). Detecting cutaneous basal cell carcinomas in ultra-high resolution and weakly labelled histopathological images.  Machine Learning for Health Workshop at NeurIPS 2019